Intriguingly, administration of a DNA‐degrading enzyme (DNaseI) in a rat model of CPB effectively reduced plasma cfDNA levels, decreasing endothelial dysfunction and reducing systemic inflammation.54 This evidence concerns the gene DNASE1 and endothelial dysfunction.